ストックスクリーナーアプリを入手
27.59
1.81%
0.49
アフターアワーズ：
27.59
前日終値:
$27.10
開ける：
$27.6
24時間の取引高:
551.68K
Relative Volume:
0.66
時価総額：
$1.60B
収益：
$868.45M
当期純損益:
$158.69M
株価収益率:
10.19
EPS:
2.7087
ネットキャッシュフロー:
$328.64M
1週間 パフォーマンス:
-0.93%
1か月 パフォーマンス:
-2.13%
6か月 パフォーマンス:
+2.03%
1年 パフォーマンス:
-16.37%
1日の値動き範囲:
$27.32
$27.81
1週間の範囲:
$26.75
$28.48
52週間の値動き範囲:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
27.59 | 1.57B | 868.45M | 158.69M | 328.64M | 2.7087 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2026-02-23 | ダウングレード | Truist | Buy → Hold |
| 2026-02-11 | 再開されました | UBS | Neutral |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Harmony Biosciences stock faces pipeline scrutiny amid Polaryx integration challenges and rare disea - AD HOC NEWS
Market Outlook: Does Harmony Biosciences Holdings Inc offer margin of safetyWeekly Trade Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Are options traders betting on a big move in Harmony Biosciences stock? - MSN
Harmony Biosciences to report Q4 and full-year 2025 results - MSN
HRMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HRMY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Are Options Investors Anticipating Significant Volatility in Harmony Biosciences Shares? - Bitget
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock? - TradingView
(HRMY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bull Bear: Is Harmony Biosciences Holdings Inc impacted by rising ratesTrade Risk Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline - MSN
FOMO Trade: Can Harmony Biosciences Holdings Inc reach all time highs this year2026 Sector Review & Momentum Based Trading Signals - baoquankhu1.vn
Can Harmony Biosciences Holdings Inc reach all time highs this year - baoquankhu1.vn
Harmony Biosciences Stock Offers a Rare Buying Opportunity - Barron's
Aug Spikes: Whats the profit margin of Harmony Biosciences Holdings Inc2026 Technicals & Fast Gain Swing Alerts - baoquankhu1.vn
Harmony Biosciences reports 2025 revenue growth, issues 2026 outlook - MSN
Deutsche Bank cuts PT on Harmony Biosciences Holdings (HRMY) to $30 from $31 - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update - MarketBeat
Zuckerman Investment Group LLC Invests $3.40 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. $HRMY Shares Sold by Nan Fung Group Holdings Ltd - MarketBeat
HRMY SEC FilingsHarmony Biosciences Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Valuation Update: Can Harmony Biosciences Holdings Inc reach all time highs this yearVolume Spike & Verified Stock Trade Ideas - baoquankhu1.vn
Harmony’s next-gen narcolepsy drug advances with surprising new results - MSN
H.C. Wainwright Remains Bullish on Harmony Biosciences Holdings (HRMY) - MSN
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates - MSN
Harmony Biosciences Reports 2025 Revenue Growth, Issues 2026 Outlook - MyChesCo
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) - MSN
HC Wainwright & Co. Maintains Harmony Biosciences Holdings (HRMY) Buy Recommendation - MSN
Harmony Biosciences Holdings, Inc. $HRMY Shares Acquired by American Century Companies Inc. - MarketBeat
Does Mixed Q4 Results and Reaffirmed WAKIX Guidance Change The Bull Case For Harmony Biosciences (HRMY)? - simplywall.st
Harmony Biosciences Holdings Inc (HRMY) Stock Price, Trades & News - GuruFocus
Harmony Biosciences Eyes Blockbuster Future After Record Year - TipRanks
HRMY Technical Analysis & Stock Price Forecast - Intellectia AI
Harmony Biosciences to Participate in Upcoming Investor Conferences - pharmiweb.com
Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook on Its Promising 45% Upside Potential - DirectorsTalk Interviews
HRMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HC Wainwright Issues Pessimistic Forecast for HRMY Earnings - MarketBeat
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31 - Bitget
Harmony Biosciences (NASDAQ:HRMY) Downgraded by Wall Street Zen to Hold - MarketBeat
MSN - MSN
Harmony Biosciences Downgrades Put Wakix Patent Risks In Sharp Focus - Yahoo Finance
HC Wainwright Issues Negative Estimate for HRMY Earnings - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Zacks Research - MarketBeat
US applications for jobless aid rose modestly to 212,000 last week as layoffs remain at historically healthy levels - Bitget
Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at the DNB Carnegie Energy & Shipping Conference in Oslo - Bitget
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments - Yahoo Finance
Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval - simplywall.st
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), CareDx (CDNA) and Sotera Health (SHC) - The Globe and Mail
20 Best Investments in 2026 - Insider Monkey
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):